Bloomberg: CVS-Aetna deal close to clearing antitrust process

Amy Baxter | | Health Exec | Policy & Regulations

CVS Health’s takeover of health insurance giant is likely close to clearing the antitrust process with the Department of Justice, Bloomberg reported last week.

The deal, which is valued at approximately $69 billion, has come under fire recently over concerns of declining market competition and consumer choice.

CVS officials were confident the deal would move forward during the company’s most recent quarterly earnings call with analysts, and even specified when they expect the transaction to close–a sign that the deal will win approval of federal regulators, according to Bloomberg.

Read the full story below:

CVS-Aetna Deal Nears Antitrust OK As Drug Plan Divestitures Loom

Amy Baxter
Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Related Content

Texas AG sues hospital for $10K after off-duty police barred from carrying guns
Cardiologists reflect on developing primary PCI in face of criticism and pushback
PBMs sue FTC for allegedly violating the Fifth Amendment
FDA issues Class I alert on Philips ventilators after 4 injuries
Trump selects Emmy-winning TV personality Dr. Oz to head CMS
FDA issues Class I recall of infusion pump batteries due to risk of burns

Around the web

Cardiovascular Business
Payment cuts and beyond: Key takeaways for cardiologists from the 2025 Medicare Physician Fee Schedule

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

AI in Healthcare
A modest proposal to rally AI regulators around a simple game plan

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

Cardiovascular Business
FDA commissioner urges clinicians to join fight against medical misinformation

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

Design by Adaptive Theme
Trimed Popup
Trimed Popup